Evidence map›Paper›PMID 26511522›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2016

Orexin signaling is necessary for hypoglycemia-induced prevention of conditioned place preference.

Oleg Otlivanchik, Nicole M Sanders, Ambrose Dunn-Meynell, Barry E Levin

Abstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Oleg OtlivanchikGraduate School of Biomedical Sciences, Rutgers University, Newark, New Jersey; Department of Neurology, New Jersey Medical School, Rutgers University, Newark, New Jersey;
Nicole M SandersSeattle Veterinary Specialists, Kirkland, Washington.
Ambrose Dunn-MeynellGraduate School of Biomedical Sciences, Rutgers University, Newark, New Jersey; Department of Neurology, New Jersey Medical School, Rutgers University, Newark, New Jersey; Neurology Service, Veterans Affairs Medical Center, East Orange, New Jersey; and.
Barry E LevinDepartment of Neurology, New Jersey Medical School, Rutgers University, Newark, New Jersey; Neurology Service, Veterans Affairs Medical Center, East Orange, New Jersey; and levin@njms.rutgers.edu.
Veterans Biomedical Research Institute · USRutgers, The State University of New Jersey · US

Funding

BRAIN GLUCOSENSING NEURONS IN HEALTH AND DIABETESR01DK053181 · NIDDK · VETERANS BIOMEDICAL RESEARCH INSTITUTE · PI LEVIN, BARRY E · 1998 to 2014
$5.6M
NIDDK NIH HHS R01-DK-53181
6 · The paper itself

Abstract

While the neural control of glucoregulatory responses to insulin-induced hypoglycemia is beginning to be elucidated, brain sites responsible for behavioral responses to hypoglycemia are relatively poorly understood. To help elucidate central control mechanisms associated with hypoglycemia unawareness, we first evaluated the effect of recurrent hypoglycemia on a simple behavioral measure, the robust feeding response to hypoglycemia, in rats. First, food intake was significantly, and similarly, increased above baseline saline-induced intake (1.1 ± 0.2 g; n = 8) in rats experiencing a first (4.4 ± 0.3; n = 8) or third daily episode of recurrent insulin-induced hypoglycemia (IIH, 3.7 ± 0.3 g; n = 9; P < 0.05). Because food intake was not impaired as a result of prior IIH, we next developed an alternative animal model of hypoglycemia-induced behavioral arousal using a conditioned place preference (CPP) model. We found that hypoglycemia severely blunted previously acquired CPP in rats and that recurrent hypoglycemia prevented this blunting. Pretreatment with a brain penetrant, selective orexin receptor-1 antagonist, SB-334867A, blocked hypoglycemia-induced blunting of CPP. Recurrently hypoglycemic rats also showed decreased preproorexin expression in the perifornical hypothalamus (50%) but not in the adjacent lateral hypothalamus. Pretreatment with sertraline, previously shown to prevent hypoglycemia-associated glucoregulatory failure, did not prevent blunting of hypoglycemia-induced CPP prevention by recurrent hypoglycemia. This work describes the first behavioral model of hypoglycemia unawareness and suggests a role for orexin neurons in mediating behavioral responses to hypoglycemia.

Indexed as

Behavior, AnimalConditioning, PsychologicalFeeding BehaviorSignal TransductionAnimalsArousalBenzoxazolesBlood GlucoseBrainDisease Models, AnimalHypoglycemiaMaleNaphthyridinesOrexin Receptor AntagonistsOrexin ReceptorsOrexins1-(2-methylbenzoxazol-6-yl)-3-(1,5)naphthyridin-4-yl ureaBenzoxazolesBlood GlucoseNaphthyridinesOrexin Receptor AntagonistsOrexin ReceptorsOrexinsSertralineUreaawarenessdiabetesperifornical hypothalamusserotonin

Identifiers

PMID26511522
PMCPMC4796633
OpenAlexW2208977122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.